SCIENTIFIC PUBLICATIONS

Article: Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study. DOWNLOAD

PRESENTATIONS

To Be Updated Soon

PR MATERIALS

LEGATO Newsletter December 2023 DOWNLOAD

LEGATO Newsletter May 2024 DOWNLOAD

PROJECT DELIVERABLES

To Be Updated Soon

Subscribe to the LEGATO newsletter

PRIVACY POLICY & LEGAL NOTICE

Facebook Youtube Linkedin

© The LEGATO Consortium 2023-2028. This project has received funding from the European Union’s HORIZON-MISS-CANCER-2022-01 under grant agreement Nº (101103655).

Copyright © 2024 All rights reserved.

Linkedin Twitter Facebook